Go to top of page
Our revised Cost Recovery Implementation Statement (CRIS) took effect on 1 July 2020. The CRIS ensures full cost recovery of all regulatory functions we provide to industry through the efficient implementation of cost recovered activities, consistent with the Australian Government Cost Recovery Guidelines.
A key focus in 2020–21 has been to maintain operations and continue to serve the Australian community and stakeholders throughout the COVID-19 pandemic, with many facing unprecedented circumstances and challenges.
We implemented business continuity arrangements to ensure our staff were equipped to work remotely with no impact to the important services we provide.
To support holders and manufacturers of veterinary medicines, we developed guidance to allow those audited by the APVMA to demonstrate compliance with Good Manufacturing Practice while travel restrictions and other measures were in place.